Federation of Korean Industries Expands 'Management Doctor Program' to Mid-sized Companies... Supporting ESG Management

[Asia Economy Reporter Suyeon Woo] The Federation of Korean Industries (FKI) Small and Medium Business Cooperation Center shared the achievements of the 'Management Doctor Program,' where management advisory committee members visit SME sites to provide management consulting, and decided to expand the advisory targets from SMEs to mid-sized companies.

On the 30th, FKI held the '2021 First Half Management Doctor Program Performance Report and Second Half Launch Ceremony.' The Management Doctor Program is a long-term advisory program in which FKI management advisory committee members visit SME sites for six months to help resolve management difficulties. It started in 2007 and is a representative win-win growth program celebrating its 15th anniversary this year.

At the event, the FKI Small and Medium Business Cooperation Center introduced excellent advisory cases from partner companies participating in the Management Doctor Program in the first half of 2021. Sungjin Precision, a partner company of Samsung Electro-Mechanics, saw a doubling of production volume and a 30% improvement in process defect rate compared to the previous year through consulting on production management. TOS, a partner company of SEMES, received advice on establishing an IPO strategy for a technology company and prepared a turning point to leap into a mid-sized company by building a next-generation management system.

In the second half of the year, 18 partner companies of 13 large corporations (Samsung Display, Samsung Electro-Mechanics, SEMES, LG Innotek, KCC, Daesang, Ottogi, Yura Corporation, POSCO Chemical, Hanwha Construction, Hyosung Heavy Industries, Hyosung TNC, Hyosung Chemical) will participate in this program. Until the end of the year, partner companies will receive the successful experiences and know-how of large corporations from management doctors with backgrounds in large corporations, not only in technology development, production, and quality control but also in the energy and environmental fields for ESG management, which companies are most interested in recently.

To this end, the target companies for the Management Doctor Program will be expanded from SMEs to mid-sized companies for support. A management diagnosis tool will be used to accurately assess corporate difficulties to enhance the advisory effect, and joint consulting will be conducted to reflect the diverse needs of participating companies and provide multifaceted advice.

This content was produced with the assistance of AI translation services.